Starting July 1, 2013, all new pharmaceutical companies operating in China must comply with China’s Food and Drug Administration (CFDA) revised Drug Quality Control Standards for license approval and GMP certification. Pharmaceutical companies with new, expanded or renovated warehouses or business locations... Read More
Asia's diagnostic imaging market is growing faster than in any other global region. It is expanding at an annual rate of 11 percent, compared to just 7 percent in the rest of the world. In 2012, the Asian diagnostic imaging market was... Read More
Together, the ten countries of the Association of Southeast Asian Nations (ASEAN) have a combined GDP of $2 trillion and a population of more than 600 million. Indonesia, Malaysia, the Philippines, Singapore, Thailand, Brunei, Myanmar (Burma), Cambodia, Laos and Vietnam made up... Read More
Asia's active pharmaceutical ingredient (API) market is worth more than $32 billion, and it is growing more quickly than any other API market, at a rate of 8 percent annually. From 2007 to 2011, Asia's portion of the world API market went... Read More
The active pharmaceutical ingredient (API) market in Asia is growing at an increasingly rapid pace. From 2007 to 2011, it went from 24.5 to 28.5 percent of the world market. From now through 2017, it should expand at a rate of 8.2... Read More
Nearly ten percent of India's 1.24 billion people suffer from chronic kidney disease (CKD), a disease in which the kidney slowly loses function and fails. One 2013 survey found that more than 15 percent of urban Indians have the disease, with rates... Read More
China’s Food and Drug Administration (CFDA) has proposed exempting 25 categories of Class II medical devices from clinical trials. Altogether, there are 142 devices on the draft list, including: Single-use, sterile tissue clamps Blood and infusion warmers Medical gas alarm systems Portable... Read More
The largest ever study of kidney disease in India has found that 17 percent of urban Indian residents have chronic kidney disease (CKD). Rates are as high as 47 percent in some cities. Most of the Indians surveyed were unaware they had... Read More
Starting July 2, 2013, the European Commission will require all Active Pharmaceutical Ingredient (API) manufacturers to meet EU current good manufacturing practice (CGMP) standards before importing products into the EU. The new regulations were passed in 2011, but countries from India to... Read More
In May 2013, India’s Drug Technical Advisory Board (DTAB) recommended requiring the audio or video recording of informed consent in Indian clinical trials. If approved by lawmakers, the new proposal will be inserted into Schedule Y of the Drugs and Cosmetics Rules.... Read More